FOXO Technologies Inc. (FOXO) Stock

FOXO Technologies Inc., headquartered in Minneapolis, Minnesota, operates as a technology platform company focused on advancing longevity science within the life insurance sector. Founded in 2019, the company specializes in developing innovative products and services designed to integrate longevity science with life insurance offerings. FOXO Technologies Inc. aims to enhance consumer engagement in health and wellness while streamlining the underwriting process for consumers.

Central to FOXO Technologies Inc.'s offerings is FOXO Labs, a cutting-edge platform that incorporates saliva-based epigenetic biomarkers into accelerated underwriting protocols. This integration aims to optimize the customer underwriting experience by leveraging scientific advancements in longevity research. Additionally, FOXO Life, another key platform offered by the company, provides a range of proprietary life insurance products alongside those from third-party carriers. These products are uniquely tailored to combine longevity science insights with traditional life insurance coverage, catering to evolving consumer needs and expectations in the insurance industry.

With a commitment to innovation and customer-centric solutions, FOXO Technologies Inc. continues to expand its footprint in the life insurance market. By harnessing the power of longevity science, the company aims to redefine how life insurance products are developed, marketed, and underwritten, positioning itself at the forefront of technological advancements that benefit both insurers and policyholders alike,